Sphingolipid metabolites as potential circulating biomarkers for sarcopenia in men
Abstract Background Sarcopenia is an age‐related progressive loss of muscle mass and function. Sarcopenia is a multifactorial disorder, including metabolic disturbance; therefore, metabolites may be used as circulating biomarkers for sarcopenia. We aimed to investigate potential biomarkers of sarcop...
Saved in:
| Main Authors: | Je Hyun Seo, Jung‐Min Koh, Han Jin Cho, Hanjun Kim, Young‐Sun Lee, Su Jung Kim, Pil Whan Yoon, Won Kim, Sung Jin Bae, Hong‐Kyu Kim, Hyun Ju Yoo, Seung Hun Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.13582 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
by: Fufangyu Zhao, et al.
Published: (2025-02-01) -
Stage-specific function of sphingolipid synthases in African trypanosomes
by: Norton Heise, et al.
Published: (2025-02-01) -
Long non-coding RNAs-sphingolipid metabolism nexus: Potential targets for cancer treatment
by: Yan Chen, et al.
Published: (2024-12-01) -
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
by: Justin R. Gregg, et al.
Published: (2024-11-01) -
Reactivation of mTOR signaling slows neurodegeneration in a lysosomal sphingolipid storage disease
by: Hongling Zhu, et al.
Published: (2025-01-01)